Typical Lung Carcinoids with Metastasis: Potential Role of MicroRNAs in the Regulation of Adaptive Immunity

Ana L Seneda1,2, Rainer M Lopez Lapa3,4, Tainara F Felix1,2

  • 1Faculty of Medicine, Department of Surgery and Orthopedics, São Paulo State University (UNESP), Botucatu, Brazil.

Abstract

Insights

This study identified 15 downregulated microRNAs (miRNAs) in lung carcinoid tumors and metastases. Key miRNAs, miR-126-3p and miR-146b-5p, and their target genes may drive lung carcinoid progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Lung carcinoids are rare neuroendocrine tumors with poorly understood molecular characteristics.
  • MicroRNAs (miRNAs) are critical gene regulators implicated in cancer development, but their role in lung carcinoids remains largely unexplored.
  • This study aimed to identify deregulated miRNAs and their target genes in typical lung carcinoid with metastasis to understand disease progression.

Observation:

  • A total of 15 significantly downregulated miRNAs were identified in lung carcinoid tumors and lymph node metastases.
  • The expression levels of miR-126-3p and miR-146b-5p were validated as decreased in an external dataset.
  • Overexpression of SOX2 and TCF4 genes, targeted by miR-126-3p, was observed in a subset of lung carcinoid samples.

Findings:

  • Downregulation of miR-126-3p and miR-146b-5p was consistently observed in lung carcinoid tumors and metastases.
  • Target gene analysis revealed that these miRNAs regulate pathways involved in adaptive immune response.
  • SOX2 and TCF4 gene overexpression, potentially driven by miR-126-3p downregulation, was noted in lung carcinoid samples.

Implications:

  • The identified downregulated miRNAs (miR-126-3p, miR-146b-5p) and their overexpressed target genes (SOX2, TCF4) are potential biomarkers for lung carcinoid progression.
  • These molecular changes may play a crucial role in the transition of typical lung carcinoids to regional metastasis.
  • Further validation in larger cohorts is warranted to confirm the clinical utility of these miRNA and gene expression alterations.